Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders

Psychiatric Clinics of North America

Volumn 24, Issue 2, 2001, Pages 315-323

  Mitchell, James E ^a,b   Peterson, Carol B ^c   Myers, Tricia ^a,b   Wonderlich, Stephen ^a,b  

^a Neuropsychiatric Research Institute   (United States)

^b UND School of Medicine & Health Sciences Southeast Campus   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

ANOREXIA NERVOSA; BODY WEIGHT; BULIMIA; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; HUMAN; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RELAPSE; REVIEW; SELF HELP;

EID: 0034993553     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70227-6     Document Type: Article

References (63)

1. Outcome predictors for the cognitive behavioral treatment of bulimia nervosa: Data from a multisite study
2. Pharmacologic and cognitive behavioral treatment for bulimia nervosa: A controlled comparison
3. Cognitive-behavioral and response prevention treatments for bulimia nervosa
4. A multisite comparison of cognitive behavior therapy (CBT) and interpersonal therapy (IPT) in the treatment of bulimia nervosa
5. Effects of a tricyclic antidepressant and opiate antagonists on binge-eating behavior in normal weight bulimic and obese binge-eating subjects
6. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
7. Treatment of bulimia with desipramine: A double-blind crossover study
8. Treatment of bulimia with fenfluramine and desipramine
9. Long-term mortality in anorexia nervosa: A 20-year follow-up of the St George's and Aberdeen cohorts
10. Prior treatment received by patients with bulimia nervosa
11. A placebo-controlled trial of d-fenfluramine in bulimia nervosa
12. Psychotherapy and bulimia nervosa: Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavioral therapy
13. Three psychological treatments for bulimia nervosa
14. A comparison of two psychological treatments for bulimia nervosa
15. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments
16. Fluvoxamine in prevention of relapse in bulimia nervosa: Effects on eating on eating-specific psychopathology
17. Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy
18. Fluoxetine in the treatment of bulimia nervosa
19. Controlled trial of psychotherapy for bulimia nervosa
20. A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa
21. The heterogeneity of anorexia nervosa: Bulimia as a distinct group
22. A comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa
23. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: Short-term outcome
24. Long-term fluoxetine treatment of bulimia
25. Treatment of bulimia nervosa with lithium carbonate: A controlled study
26. Treating bulimia with desipramine: A double-blind placebo-controlled study
27. Naltrexone and bulimic symptoms
28. Naltrexone reverses bulimic symptoms
29. Treatment of antidepressant-resistant bulimia with naltrexone
30. Medical and nutritional assessment
31. Double-blind placebo-controlled administration of fluoxetine in restricting-type anorexia nervosa
32. Long-term outcome of bulimia nervosa
33. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine
34. A trial of isocarboxazid in the treatment of bulimia nervosa
35. Comparison of two group treatments for bulimia
36. Bulimia nervosa, binge-eating, and psychogenic vomiting: A controlled treatment study and long-term outcome
37. Meta-analysis of treatment studies for bulimia
38. Cognitive-behavioral group therapy for bulimia
39. Exposure plus response-prevention treatment of bulimia nervosa
40. Comparison of cognitive behavior therapy and desipramine in the treatment of bulimia nervosa
41. A placebo-controlled double-blind cross-over study of naltrexone hydrochloride in outpatients with normal weight bulimia
42. A placebo-controlled double-blind trial of amitriptyline in bulimia
43. Electrolyte and other physiological abnormalities in patients with bulimia
44. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment for bulimia nervosa
45. Utilization of empirically supported psychotherapy treatments for individuals with eating disorders: A survey of psychologists
46. Cognitive-behavioral therapy for bulimia: An initial outcome study
47. Bulimia treated with imipramine: A placebo-controlled, double-blind study
48. A placebo-controlled study of trazodone in bulimia nervosa
49. A collaborative approach to the use of medication
50. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives
51. Bulimia nervosa: An ominous variant of anorexia nervosa
52. Bulimia nervosa: A placebo-controlled double-blind therapeutic trial of mianserin
53. The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study
54. Mortality in anorexia nervosa
55. Sequential treatment for bulimia nervosa incorporating self-care manual
56. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa: A double blind placebo-controlled cross-over study
57. Long-term outcome of antidepressant treatment for bulimia nervosa
58. Treatment of bulimia with phenelzine: A double-blind placebo controlled study
59. Medication and psychotherapy in the treatment of bulimia nervosa
60. Cognitive behavioral treatment with and without response prevention for bulimia
61. Cognitive behavioral treatment of bulimia nervosa: A controlled evaluation